The first Esperion Therapeutics trade was made in Q4 2014.
Since then Steven Cohen bought shares seventeen more times and sold shares on thirteen occasions. The investor completely sold their stake between Q3 2024 and Q3 2024.
Avg closing price
Price range
Sold -67.1 Thousand shares
Q3 2024
Avg closing price
$2.02
Price range
$1.61
-
$2.73
Increased shares by 317.4% (+51 Thousand shares)
Q2 2024
Avg closing price
$2.35
Price range
$1.84
-
$3.24
Increased shares by 234.8% (+11.3 Thousand shares)
Q1 2024
Avg closing price
$2.43
Price range
$2.02
-
$3.02
Sold 99.8% shares (-3.09 Million shares)
Q4 2023
Avg closing price
$1.30
Price range
$0.73
-
$3.08
Sold 37.7% shares (-1.88 Million shares)
Q3 2023
Avg closing price
$1.45
Price range
$0.96
-
$1.79
Increased shares by 38.2% (+1.38 Million shares)
Q2 2023
Avg closing price
$1.40
Price range
$1.20
-
$1.76
Increased shares by 58.1% (+1.32 Million shares)
Q1 2023
Avg closing price
$5.16
Price range
$1.46
-
$7.30
Sold 18.3% shares (-511 Thousand shares)
Q4 2022
Avg closing price
$7.15
Price range
$5.09
-
$8.56
Increased shares by 162.3% (+1.73 Million shares)
Q3 2022
Avg closing price
$6.87
Price range
$5.45
-
$8.13
New holding (+1.06 Million shares)
Q2 2022
Avg closing price
$5.67
Price range
$4.77
-
$6.67
Sold -648 Thousand shares
Q2 2021
Avg closing price
$24.08
Price range
$19.40
-
$28.71
New holding (+648 Thousand shares)
Q1 2021
Avg closing price
$29.50
Price range
$25.12
-
$36.89
Sold -4.8 Thousand shares
Q1 2020
Avg closing price
$52.77
Price range
$27.44
-
$73.84
Sold 98.9% shares (-415 Thousand shares)
Q4 2019
Avg closing price
$44.96
Price range
$35.40
-
$59.82
Increased shares by 528.1% (+353 Thousand shares)
Q3 2019
Avg closing price
$39.61
Price range
$34.47
-
$47.53
Sold 69.2% shares (-150 Thousand shares)
Q2 2019
Avg closing price
$46.96
Price range
$40.10
-
$52.33
New holding (+217 Thousand shares)
Q1 2019
Avg closing price
$44.86
Price range
$40.11
-
$53.57
Sold -507 Thousand shares
Q4 2018
Avg closing price
$48.18
Price range
$36.99
-
$59.11
Increased shares by 39.3% (+143 Thousand shares)
Q3 2018